Spicy cross between Cristina Pérez and Ginés González García – News

The Minister of Health Ginés González García starred in an intense round trip with the driver, Cristina Perez, about the extension of the quarantine after it was announced that Argentina will participate in the production of the coronavirus vaccine developed by the University of Oxford.

“We have a specific medium-term horizon, but in the meantime there is no other than to continue taking care of ourselves and complying, as in this first stage of the pandemic,” he said.

“I am sorry that there are some outdated messages that I think are not good. We are going to lose something that cost us a lot to build, which is to be one of the three countries with the lowest specific mortality in America with respect to this terrible pandemic,” he added.

The official said that it is not yet possible to specify when the contagion will begin to give way: “It has to be a collective construction, it does not depend only on what the State does.”

And he cited the case of Jujuy: “As it was fantastic, he thought it was all over and exploded.”

/ Embedded Code Home // End Embed Code /

In this, Pérez asked him why, instead of seeking “what is repressive and punitive”, the Government does not propose protocols for social or family gatherings.

Ginés responded: “All the investigations of the last month say that practically all the origin of the outbreaks – and some of them, explosives – are social encounters. They are not for necessities of life, they are very social”.

And at that point, he stressed that the difficulty of generating protocols for these meetings is that there people take off their masks, they do not respect the distance and they spend a lot of time.

“All the conditions are in place for a contagion like the one that occurs, very massive. It is not that it is repressive or that we take away their freedom. The truth is that I do not understand laws, I always ask for it, I never say that I am going to do anything to those who do not, I simply try to persuade and convince, “he said.

Ginés added: “If we do not have the will of some … Those who have a little more freedom or those who are younger and feel they have less risk do it many times. I understand them, but we are asking them to be a few months, until this storm passes, so that we do not have the consequences that others have. “

Before that, the journalist pointed out that Argentina has the “longest quarantine in the world.” “Yes, and it has the best results in the world,” she replied, to which the journalist retorted: “In the world?”

Ginés explained that the country “is among the best”: “That is what the outsiders say, not those from here. I do not understand what campaign they want to do to say that it is the longest, that it ended … It did not end, it continues. If someone tells us that there is a better recipe, we will make it. The clear and concrete recipe is this. If we don’t want to hear it or we’re angry, that has to do with individual freedom. “

The official also criticized those who want to politically “take advantage” of the country’s situation due to the coronavirus. “They will know the responsibility they have,” he said, and Cristina Perez He added: “If someone thinks differently, it is not the enemy either, Minister.” “I am not saying that they are the enemy, but you know that there is political speculation,” Ginés continued.

“I do not like being the unfriendly who says this, but there is no alternative and we have looked for them all,” he closed.

Look also

Awkward moment on TV

.

Trump Responds to Putin’s Sputnik V with a $ 1.3 Billion Contract for Moderna | Companies

US President Donald Trump appeared swiftly to the media on Tuesday night before the propaganda effect of his Russian counterpart Vladimir Putin saying that they had approved the world’s first vaccine against the coronavirus, called Sputnik V. Trump took out the checkbook and announced that it was paying 1.5 billion dollars (1.3 billion euros) for 100 million doses of the experimental vaccine from the biopharmaceutical company Moderna, which saw its price boosted again at the beginning of the Wall Street session due to the news.

Trump, in the middle of the pre-election period, advanced that his government is “very close” to approving the vaccine. Without citing the Kremlin’s achievement, from the White House he referred to the huge resources that the US is allocating to the development of these products by several multinational pharmaceutical companies. “We are investing in the development and manufacture of the six main candidates to ensure their rapid distribution, and the Armed Forces are ready to deliver the vaccine to Americans as soon as the first one is fully approved,” the president said. “And we are very close to that approval.”

The Trump administration, in fact, has become the true financial lung of the greatest advances in hope in the face of SARS-CoV-2. His Administration launched Operation Warp Speed ​​(or maximum speed) to finance the development of vaccines, treatments and diagnostic tools with total funds of 10,000 million. This has helped the laboratories boost their research and test with thousands of patients throughout the world.

Moderna is one of those benefited companies. The others are Janssen, MSD, Britain’s AstraZeneca (together with the University of Oxford), Pfizer, Vaxart, Inovio and Novavax. In Moderna’s case, yesterday’s announcement means paying $ 15 for each dose, which means that the complete vaccination with the two doses will cost $ 30. Although in reality the Trump administration has previously funded another $ 955 million in grants to the company.

Moderna’s vaccine is one of the most advanced in the world in human trials, according to the World Health Organization (WHO) list dated August 10. Its experimental product mRNA-1273 is among the 28 that are already being tested in humans and, specifically, it is one of the six in the last phase (immunizing thousands of volunteers) before its approval by the health authorities. Thanks to this supply contract, Moderna’s shares rose by around 10% at the beginning of the session, although they later stabilized.

Trump promised that by the time one of the candidates is approved, 100 million doses will be available to vaccinate Americans and also pointed out that “shortly after” 500 million more will be produced.

Although Trump neither referred nor was asked about the Russian vaccine, his Health Secretary Alex Azar did: “The point is not to be the first, the point is to have a safe and effective vaccine for Americans and for people in the world ”and demanded from the Kremlin“ transparent data ”.

Putin had announced hours before that he approved Sputnik V, arousing misgivings in the international community, since that product has only been tested in 38 volunteers and, according to the WHO, is in phase I of clinical trials so it should still test safety and efficacy in thousands of people. The Russian Executive trusts that the first doses of the vaccine will be available at the end of August or the beginning of September, which will be destined for health personnel. The rest of the citizens will be able to have access to the vaccine as of January 1 next.

Advances for Pfizer

Vaccine. The vaccine candidate developed by Pfizer has been shown to induce a robust immune response in a preliminary clinical trial conducted with 45 healthy adults aged 18 to 55 years, the results of which were published this Wednesday in the journal Nature. The provisionally called BNT162b1 is the most promising of the four developed by the American pharmaceutical company and the German company BioNTech. This product is in phase II, so it would need to advance one more stage of studies with thousands of volunteers.

Outcome. The study found that BNT162b1 was generally well tolerated, although some participants experienced mild to moderate side effects, which increased with the dose level. Antibodies against SARS-CoV-2 remained 21 days after the first vaccination.

.

Kaiser Permanente participates in COVID-19 vaccine trial in Portland | News

PORTLAND, OR (KPTV) – Portland could become instrumental in fighting the COVID-19 pandemic, as clinical trials for a new vaccine could begin here as early as next week.

Kaiser Permanente in Portland is taking the reins on the research as the vaccine will be tested on thousands of people.

The vaccine is moving into the final stages of testing, with researchers moving closer to getting the vaccine on the market to bring the COVID-19 pandemic to an end.






KPTV image.


“I mean, really, we look around the world and the horrific impact this pandemic has had,” Britta Torgrimson-Ojerio with Kaiser Permanente Center for Health Research said. “The human toll, the social toll, the economic toll, and having an effective vaccine is really what we need to get us back to our normal lives.”

The Kaiser Permanente Center for Health Research will begin clinical trials over the next few weeks for the vaccine.

“Soon, we’ll be able to start looking at that data and start to really understand this particular vaccine,” Torgrimson-Ojerio said. “We need to compare it to a placebo, so compare it to basically nothing, to see if it actually is effective.”

The healthcare provider says Portland is one of four sites in the United States that plans to test around 1,400 patients. The trial will ultimately test the vaccine on 30,000 people around the world.

“What we want to see is that the safety continues to look really good for this and we can continue to understand how effective it is,” Torgrimson-Ojerio said.

This will be the final stages of testing, where researchers say they hope to understand how long the vaccine can prove to be effective. While the vaccine is in its final stage, there is no timeline yet for when it could potentially be available, Kaiser Permanente says.

“Everyone wants to do this as quickly as possible but then at the same time we really have to make sure that we have all the data we need and that we can really understand it,” Torgrimson-Ojerio said.

Kaiser Permanente says it will send emails and flyers to qualified members to see their interest in participating in the study. Portland’s researchers say they are excited to be a part of these trials and what they could mean on a global level.

Copyright 2020 KPTV-KPDX Broadcasting Corporation. All rights reserved.

.

The Oxford vaccine would begin to be applied in risk groups before the end of the year

The Minister of Health of the Nation, Ginés González García, said that the Oxford vaccine that will begin to be produced in Argentina will be for the elderly, health workers and those who have some type of previous pathology that makes them vulnerable .

“With that, it begins as in all vaccinations and then we will see how far it extends, because clearly as with other vaccines, the level of how far we are going to go in immunity will be determined by the evolution of the pandemic itself and we believe that with this it is going to have a very strong blow with respect to this evolution, “the minister explained.

González García said they are “happy and proud”, because they are trying to ensure “according to what the Government proposed from the first moment”, access to the vaccine and the moment of access to the vaccine. And he added that also a way to ensure access is that the price is reasonable.

And in that sense he said: “we are also proud because it is not easy to produce the raw material for a vaccine of this complexity and finally that we have the national production capacity fills us with pride.”

The existence of a kind of clause called “emergency use” between laboratories and countries would allow its application while the corresponding permits are being processed, but once phase 3 of development is completed, since it would be applied to healthy people, and that in Argentina it could occur in the month of December, that is, before the end of 2020.

“It isthe vaccine comes to the fore in the world in terms of the moment of the clinical phase in which it is. As of July 20, there are already publications that in the first studies that are being carried out in different countries of the world give an extraordinary immunity capacity that the vaccine has with a single dose. 91 percent of the patients who used the vaccine had immunity, “the minister stressed.

However, González García remarked that “it is neither the only negotiation nor the only alternative. We continue to work with the clinical experience that another provider is carrying out in our country. First to ensure which is the best or the most effective and second in which At the moment we can mount it so that Argentines are immunized.

“Before the studies of the experimental phase are finished, it is beginning to be produced. That is what the president said that ‘it is at risk’. If the vaccine were not useful in reality, everything that has been invested in that manufacturing. And the fact that it is done here in Argentina ensures at least a long time, with respect to what was foreseeable from other suppliers, “he said, adding that” the idea that these investigations are led by countries of the The northern hemisphere could potentially put us at risk regarding access. In this way we are taking definitions that ensure access. “

.

Coronavirus vaccine trials began in the country – News

The tests of the vaccine against Covid-19 began in Argentina with the applications to the first volunteers.

The study is carried out at the Central Military Hospital of the City of Buenos Aires by a work team that includes more than 500 professionals, and is led by Dr. Fernando Polack, Dr. Gonzalo Pérez Marc and Dr. Romina Libster.

Of the more than 20,000 registered volunteers from the AMBA region, approximately 4,500 are being selected to participate in the same.

To be a volunteer in this phase of the clinical study of the vaccine, people must be between 18 and 85 years old, in addition to not having been infected with the coronavirus.

Half of the participants will receive the vaccine in development and half a placebo, in a study design called “double blind”, in which neither the treating physicians nor the volunteers know the content of the administered product.

This will ensure the complete objectivity of the results that will be obtained in order to demonstrate the efficacy of the vaccine under development.

All participants will receive a second dose after 21 days, and will remain under strict clinical control for at least two years. However, the first preliminary results are expected in a few months, which will allow the efficacy of the vaccine to be evaluated by the regulatory authorities.

The study of this vaccine, called BNT162b2 and developed by Pfizer and BioNTech, has already successfully gone through phases 1 and 2 of the trial in the US and Germany, and will include a total of 30,000 volunteers globally in more than 120 institutions in at least 3 countries in its phase 3: USA, Argentina and Brazil.

The research sites were selected based on their experience in this type of study and their logistical capacity to adapt to the demands of research during the pandemic.

.

Russian Corona Vaccine Ready for Use, Scientists Doubt Its Safety

KOMPAS.com – A number of candidates vaccine virus Corona is in the clinical trial phase to confirm the safety and efficacy of the vaccine.

However, President Russia Vladimir Putin instead announced on Tuesday (11/8/2020) that the country’s health officials had become the first in the world to approve use corona vaccine extensively.

This then sparked anger scientist around the world and condemned the decision as a hasty dangerous act.

The reason is, as quoted from Nature, Wednesday (12/8/2020), Russia has not finished testing great for testing the safety and efficacy of these vaccines.

Also read: Forward to the next stage, the British Corona Vaccine Candidates will be tested to 30,000 people

Researchers assess that launching the corona vaccine in a hurry could harm people who receive it. In addition, it will hamper global efforts to develop immunization Covid-19 quality.

“Russia may miss steps like that. That’s what worries the vaccine scientist community. If they get it wrong, it could ruin an entire global company,” said Peter Hotez, a vaccine scientist at Baylor College of Medicine in Houston, Texas.

Francois Balloux, a geneticist at University College London published by the UK Science Media Center, called Russia’s decision “ very flippant. ” Vaccinations bulk vaccines with incorrectly tested are unethical, says Balloux.

Shutterstock Corona vaccine illustration

Also read: Scientists in the UK Develop Counterfeit Vaccines to Fight Covid-19

“Any problem with the campaign vaccination Russia will be catastrophic both through its negative health effects, but also because it will further hinder vaccine acceptance in the population, “explained Balloux.

In his announcement, Vladimir Putin said that Russian regulators had approved the vaccine corona virus, although the phase 3 trial is not yet complete.

In a phase 3 trial, it will involve giving thousands of people a vaccine or placebo injection, and then seeing if the vaccine can prevent disease.

Next, investigators should confirm vaccine safety and look for rarer side effects that may not have been observed in early-stage trials.

.

Revealed! These Are Side Effects of the Covid-19 Vaccine

Jakarta, CNBC Indonesia – Fever and swelling are two side effects that are often felt after immunization, as well as side effects of the Covid-19 vaccine.

Head of the Covid-19 Vaccine Research Team at Padjadjaran University, Dr. Kusnandi Rusmil, said that as many as 30% of volunteers who were injected with the Covid-19 vaccine could experience this.

“As many as 30% of those injected will swell, fever like immunization at Posyandu, will disappear for 2 days,” he told CNBC Indonesia in Jakarta, Wednesday (12/8/2020).

As with children who are immunized, swelling and fever are commonplace. Fever medicine to reduce fever to compress the swollen area can be done.

“The problem is the local reaction. Usual, we just need to add hot medicine,” he said.

One of the volunteers who will get the Covid-19 vaccine injection is the Governor of West Java, Ridwan Kamil. He explained about the Covid-19 vaccine that Bio Farma will produce in Bandung. One explanation is about side effects.

“The side effects of vaccines are usually what I know and according to confirmation is sometimes a momentary fever or swelling from the injection. Usually only two of them. And people can still be active after being injected,” he said.

He emphasized that vaccines are a form of prevention to increase human immunity through immunization. This vaccine is produced from a virus that spreads in the community.

“The vaccine that will be presented by Bio Farma is from a virus that has been killed, then two injections,” he concluded.

[Gambas:Video CNBC]

(Drums / drums)


.

Modern-US Agreement per 100 million doses – CNN

(CNN) — The administration Trump has reached an agreement with Moderna Inc. to manufacture and deliver 100 million doses of the company’s covid-19 vaccine once it is approved, according to a press release from the Department of Health and Human Services.

President Donald Trump announced the deal during a press conference on Tuesday.

Moderna is one of several companies that make the vaccine “at risk,” as the industry calls it, meaning that the company currently makes the vaccine before it is approved. Clinical trials are currently underway to test whether it is safe and effective.

LOOK: ANALYSIS | Russia proclaims victory in the vaccine race. But would you trust a Vladimir Putin vaccine?

Under this contract, the vaccines would be owned by the US Government and would be distributed and used as part of its vaccination campaign against COVID-19. If the doses are used, they would be provided to Americans at no cost. The government can also purchase up to 400 million additional doses of this vaccine.

The vaccine, called mRNA-1273, was developed by Moderna in collaboration with the Government of U.S. It was supported by development assistance from the National Institute of Allergy and Infectious Diseases and the US Advanced Biomedical Research and Development Authority (BARDA) supported advanced stage clinical trials and helped scale up the making. Moderna’s advanced-stage clinical trial, which began July 27, is the first government-funded phase 3 clinical trial for a COVID-19 vaccine in the United States.

This contract is part of the Operation Warp Speed from the US Government, the strong and rapid federal push to bring vaccines and therapies to market safely as soon as possible. The Health Department said the goal is to provide effective vaccines to Americans by the end of the year.

The government also reached an agreement with Pfizer in July to produce 100 million doses of its vaccine. In August, it agreed to a similar 100 million-dose deal with Janssen, the vaccine arm of Johnson & Johnson. It has other agreements with GlaxoSmithKline, Sanofi Pasteur, Novavax and AstraZeneca.

There are 28 covid-19 vaccines in human trials, according to the World Health Organization.

Why is Mexico ideal for covid-19 vaccine testing? 2:21

“By creating a portfolio of vaccines for Operation Warp Speed, the Trump Administration is increasing the likelihood that the United States will have at least one safe and effective vaccine by 2021, ”Health Secretary Alex Azar said in the press release Tuesday. “Today’s investment represents the next step in supporting this vaccine candidate from early development by Moderna and the National Institutes of Health, through clinical trials and now large-scale manufacturing, with the potential to generate hundreds of millions of safe and effective doses for the American people.

.

Coronavirus, there is a clash over the mandatory nature of the vaccine | Hope: “First doses to the doctors”

Debate triggered by Renzi – The debate on the mandatory nature of vaccines was triggered by Matteo Renzi after Prime Minister Conte expressed his opposition. “If the vaccine arrives it must be mandatory and not optional”, the leader of Italia Viva replied, finding the support of the Minister of the Family Elena Bonetti and then sparking a discussion that now divides the majority.

Technical-scientific committee: “No obligation needed” – The technical-scientific committee, according to the newspaper La Stampa, has not officially placed the mandatory nature of the vaccine at the center of the discussion but is on Prime Minister Conte’s line of thinking. Making the vaccine mandatory is useless. Considering the reasoning put forward by Renzi, according to which the obligatory nature would serve to counter No-vax and deniers, according to the CTS the former represent about 1% of the population and the latter 15%. Therefore, if the remaining 80% of the population gets vaccinated, the goal of blocking the circulation of the virus would be achieved without imposing anything on anyone.

The economic aspect and the compensation – Then there is a “side” aspect. Normally vaccines are tested for at least 5 years but the one to fight the coronavirus also involves a fight against time. Reason why, with trials that last months and not years, the risk of side effects appears: imposing the obligation can also mean risking to receive compensation requests.

Ricciardi: “Obligation only for children and certain workers” – On the line of Prime Minister Conte, who expressed himself in favor of voluntary prophylaxis, there is also Walter Ricciardi, WHO member scientist and advisor to the Minister of Health Walter Ricciardi. “I believe that the vaccine should be compulsory only for children, who must be protected because they depend on others, but not for adults. With the exception of health or public utility personnel, such as policemen, firefighters, those who work in canteens . Of all those who, in short, do jobs for which, without a vaccine, they would put the health of others at risk “.

The immunologist: “70% of Italians must get vaccinated” – Antonella Viola, full professor of Immunology at the University of Padua, spoke, again at La Stampa, about percentages and responsibilities. “You have to be sure that Italians respond to at least 70%. If that happened like with the Immuni app, which was downloaded by only 4 million people, it would be a big problem,” he said. For this “the government must take its responsibilities”.

“We need an awareness campaign” – Then he added: “If only 30% of Italians were vaccinated, it would be useless and what would we do? Would we continue in the presence of a vaccine to live with distances, masks and half-empty trains?”. According to Antonella Viola, moreover, “if you do not want to get to the mandatory vaccine you need an awareness campaign to explain to everyone that it is useful and safe. The problem is: will the young people who now go to Greece and Croatia get vaccinated?” .

.